990 related articles for article (PubMed ID: 18047564)
1. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
2. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
[TBL] [Abstract][Full Text] [Related]
3. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
Liu Y; Yang R
J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
[TBL] [Abstract][Full Text] [Related]
4. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
5. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
[TBL] [Abstract][Full Text] [Related]
6. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
[TBL] [Abstract][Full Text] [Related]
7. Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma.
Ochiai T; Sonoyama T; Hironaka T; Yamagishi H
Hepatogastroenterology; 2003; 50(51):750-5. PubMed ID: 12828078
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma.
Kaibori M; Tanigawa N; Matsui Y; Kwon AH; Sawada S; Kamiyama Y
Anticancer Res; 2004; 24(3b):1929-33. PubMed ID: 15274379
[TBL] [Abstract][Full Text] [Related]
9. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
[TBL] [Abstract][Full Text] [Related]
10. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients.
Di Carlo V; Ferrari G; Castoldi R; De Nardi P; Bergamo C; Taccagni G; Salvioni M; Angeli E; Venturini M; Del Maschio A
Hepatogastroenterology; 1998; 45(24):1950-4. PubMed ID: 9951846
[TBL] [Abstract][Full Text] [Related]
12. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.
Pandey D; Lee KH; Wai CT; Wagholikar G; Tan KC
Ann Surg Oncol; 2007 Oct; 14(10):2817-23. PubMed ID: 17690940
[TBL] [Abstract][Full Text] [Related]
13. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.
Lee SG; Hwang S; Jung JP; Lee YJ; Kim KH; Ahn CS
Br J Surg; 2007 Mar; 94(3):320-6. PubMed ID: 17205495
[TBL] [Abstract][Full Text] [Related]
16. Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.
Kaibori M; Matsui Y; Kitade H; Kwon AH; Kamiyama Y
Hepatogastroenterology; 2003; 50(50):491-6. PubMed ID: 12749254
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
Zhou WP; Lai EC; Li AJ; Fu SY; Zhou JP; Pan ZY; Lau WY; Wu MC
Ann Surg; 2009 Feb; 249(2):195-202. PubMed ID: 19212170
[TBL] [Abstract][Full Text] [Related]
18. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
20. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
